Axonics Modulation Technologies Inc logo

Axonics Modulation Technologies Inc Share Price Today (NASDAQ: AXNX)

Axonics Modulation Technologies Inc share price is $0 & ₹0.00 as on 13 Nov 2024 IST

-70.98

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 14 Nov 2024

View live Axonics Modulation Technologies Inc share price in Dollar and Rupees. Guide to invest in Axonics Modulation Technologies Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Axonics Modulation Technologies Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Axonics Modulation Technologies Inc (AXNX) Key Statistics

in dollars & INR

Previous Close
$70.98
Open
$70.5
Market Capitalization
$3.6B
Today's Volume
$4.1M
Revenue TTM
$431.9M
EBITDA
$5.3M
Earnings Per Share (EPS)
$-0.1
Profit Margin
-1.31%
Quarterly Earnings Growth YOY
8.45%
Return On Equity TTM
-0.89%

How to invest in Axonics Modulation Technologies Inc Stock (AXNX) from India?

It is very easy for Indian residents to invest directly in Axonics Modulation Technologies Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Axonics Modulation Technologies Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Axonics Modulation Technologies Inc or AXNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Axonics Modulation Technologies Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Axonics Modulation Technologies Inc shares which would translate to null fractional shares of Axonics Modulation Technologies Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Axonics Modulation Technologies Inc, in just a few clicks!

Global Institutional Holdings in Axonics Modulation Technologies Inc

  • Vanguard Group Inc

    9.91%

  • BlackRock Inc

    8.49%

  • Eckert Corp

    4.26%

  • Fidelity International Ltd

    3.99%

  • Soros Fund Management LLC

    3.47%

  • Westchester Capital Management LLC

    2.65%

Analyst Recommendation on Axonics Modulation Technologies Inc

Rating
Trend

Hold

    35%Buy

    65%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Axonics Modulation Technologies Inc(by analysts ranked 0 to 5 stars)

About Axonics Modulation Technologies Inc

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation.
Organization
Axonics Modulation Technologies Inc
Employees
797
CEO
Mr. Raymond W. Cohen
Industry
Health Technology

Important FAQs about investing in AXNX Stock from India :

Can Indians buy Axonics Modulation Technologies Inc shares?

Yes, Indians can invest in the Axonics Modulation Technologies Inc (AXNX) from India.

With INDmoney, you can buy Axonics Modulation Technologies Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Axonics Modulation Technologies Inc at zero transaction cost.

How can I buy Axonics Modulation Technologies Inc shares from India?

It is very easy to buy Axonics Modulation Technologies Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Axonics Modulation Technologies Inc (AXNX) be purchased?

Yes, you can buy fractional shares of Axonics Modulation Technologies Inc with INDmoney app.

What are the documents required to start investing in Axonics Modulation Technologies Inc stocks?

To start investing in Axonics Modulation Technologies Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Axonics Modulation Technologies Inc?

Today's market capitalisation of Axonics Modulation Technologies Inc AXNX is 3.6B

Who is the Chief Executive Officer (CEO) of Axonics Modulation Technologies Inc ?

Mr. Raymond W. Cohen is the current Chief Executive Officer (CEO) of Axonics Modulation Technologies Inc.